Wave Life Sciences (WVE) Retained Earnings (2014 - 2026)
Wave Life Sciences' (WVE) quarterly Retained Earnings came in at -$1.4 billion in Q2 2026, down 16.61% YoY from -$1.7 billion in Q2 2025, and down 5.13% on a QoQ basis from -$1.4 billion in Q1 2026.
Wave Life Sciences (WVE) Retained Earnings (2014 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 13 years of Retained Earnings data on file, last reported at -$1.4 billion in Q2 2026.
- Quarterly Retained Earnings fell 16.61% year-over-year to -$1.4 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.4 billion (down 16.61% YoY) and the FY2025 annual result came in at -$1.3 billion, down 18.22% from the prior year.
- Retained Earnings eased to -$1.4 billion in Q2 2026, from -$1.4 billion in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of -$843.3 million in Q1 2022 to a low of -$1.4 billion in Q2 2026.
- A 5-year average of -$1.1 billion and a median of -$1.1 billion in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings fell 20.09% — and 2023, when it slipped 5.95%.
- Tracing WVE's Retained Earnings over 5 years: stood at -$967.3 million in 2022, then fell by 5.95% to -$1.0 billion in 2023, then dropped by 9.47% to -$1.1 billion in 2024, then retreated by 18.22% to -$1.3 billion in 2025, then retreated by 7.2% to -$1.4 billion in 2026.
- The last three Retained Earnings figures came in at -$1.4 billion (Q2 2026), -$1.4 billion (Q1 2026), and -$1.3 billion (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | -1.42 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.42 Bn |
| Mar 31, 2026 | -254,000.00 |
| Dec 31, 2025 | 228.37 Mn |
| Sep 30, 2025 | 174.08 Mn |
| Jun 30, 2025 | 167.60 Mn |
| Mar 31, 2025 | -1.17 Bn |
| Dec 31, 2024 | -1.12 Bn |
| Sep 30, 2024 | -1.15 Bn |
| Jun 30, 2024 | 135.60 Mn |
| Mar 31, 2024 | -198,000.00 |
| Dec 31, 2023 | -124,000.00 |
| Sep 30, 2023 | -182,000.00 |
| Jun 30, 2023 | -150,000.00 |
| Mar 31, 2023 | 122.19 Mn |
| Dec 31, 2022 | -29,000.00 |
| Sep 30, 2022 | -123,000.00 |
| Jun 30, 2022 | -884.62 Mn |
| Mar 31, 2022 | 91.95 Mn |
| Dec 31, 2021 | 181,000.00 |
| Sep 30, 2021 | 84.25 Mn |